Literature DB >> 6463075

Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area.

J Stewart.   

Abstract

In rats trained to self-administer heroin or cocaine intravenously, non-contingent priming injections of heroin or cocaine, respectively, reinstated responding after a period of extinction. In rats similarly trained to self-administer heroin or cocaine intravenously, morphine sulphate was applied centrally to sites in the ventral tegmental area (VTA), the periventricular grey (PVG) and the caudate nucleus following a period of extinction. Self-administration behavior was reinstated by morphine application to sites in the region of the VTA, but not to other sites, in both heroin and cocaine-trained animals. This priming effect of morphine was blocked or attenuated by prior administration of naltrexone, given intraperitoneally. Morphine in the VTA is known to activate mesolimbic dopamine neurons, suggesting that dopamine activity in this system may underlie the priming effects of both opiates and stimulants. Furthermore, the fact that the mesolimbic system is implicated in the positive motivational actions of both drug groups, suggests that morphine reinstates drug-taking behavior in these animals by activating appetitive motivational systems of the brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6463075     DOI: 10.1016/0091-3057(84)90017-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  63 in total

Review 1.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

Review 2.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

Review 3.  Advances in the pharmacological treatment of pathological gambling.

Authors:  Jon E Grant; Suck Won Kim; Marc N Potenza
Journal:  J Gambl Stud       Date:  2003

4.  Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment.

Authors:  J L Neisewander; D A Baker; R A Fuchs; L T Tran-Nguyen; A Palmer; J F Marshall
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

5.  Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats.

Authors:  Jishi Wang; Qin Fang; Zhonghua Liu; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2005-12-23       Impact factor: 4.530

Review 6.  Animal models of drug craving.

Authors:  A Markou; F Weiss; L H Gold; S B Caine; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats.

Authors:  A D Lê; A Wang; S Harding; W Juzytsch; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

8.  Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit.

Authors:  Jasmine J Yap; Klaus A Miczek
Journal:  Drug Discov Today Dis Models       Date:  2008

9.  Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists.

Authors:  C Fahlke; E Hård; C J Eriksson; J A Engel; S Hansen
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  Cocaine seeking over extended withdrawal periods in rats: time dependent increases of responding induced by heroin priming over the first 3 months.

Authors:  Lin Lu; Jack Dempsey
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.